The Biology and Diagnosis of ADTKD-UMOD
At a Glance
ADTKD-UMOD is an inherited kidney disorder in which misfolded uromodulin builds up inside kidney cells and causes tubule scarring. Because urine may show little protein or blood, genetic testing is usually more informative than a nonspecific biopsy.
Understanding the biology of ADTKD-UMOD helps explain why your kidneys are struggling and why your diagnostic journey might have felt different from other kidney patients. Unlike more common conditions that primarily damage the kidney’s “filters,” this disease is a problem of cellular misfolding within the kidney’s “plumbing” [1][2].
The Biology: A Cellular Traffic Jam
The UMOD gene provides the blueprint for uromodulin, the most common protein in human urine. In a healthy kidney, uromodulin is produced, folded into a specific shape, and sent out of the cell to protect the urinary tract from infections and stones [1].
In ADTKD-UMOD, a genetic mutation causes the uromodulin protein to “misfold” into the wrong shape. This leads to a destructive chain reaction:
- ER Accumulation: The misfolded proteins cannot leave the cell. They get stuck in the endoplasmic reticulum (ER), which is the cell’s “shipping and receiving” department [2][3].
- Cellular Stress: As the misfolded proteins build up, they trigger a stress response (the unfolded protein response). The cell tries to fix the problem but eventually becomes overwhelmed [4][5].
- Fibrosis and Scarring: This chronic stress leads to inflammation and the death of kidney cells. The body replaces these functional cells with scar tissue, a process called fibrosis [6][7].
This damage happens primarily in the tubules (the tubes that process urine). However, secondary changes to the glomeruli (the filters) can also occur, or patients might develop an additional kidney disease.
The “Bland” Diagnosis
Because ADTKD-UMOD is a tubulointerstitial disease, your diagnostic results may look surprisingly “normal” even as your kidney function declines [8]. Doctors often look for these typical clues:
- Bland Urine Sediment: Most kidney diseases cause visible signs in the urine, such as blood cells or cellular “casts.” In ADTKD-UMOD, the urine is usually clear or “bland” [9].
- Little to No Proteinuria: Many kidney patients leak high amounts of protein into their urine. In ADTKD-UMOD, protein levels are usually very low or absent [1][9].
- Normal or Small Kidneys: Unlike Polycystic Kidney Disease (ADPKD), where kidneys become very large and filled with cysts, kidneys in ADTKD-UMOD are usually normal-sized or small. While small cysts may appear in the middle of the kidney (the medulla), they are not always present and are not required for a diagnosis [10][11].
Note: While bland urine is typical, it is not proof. Finding new or increasing blood or albumin in your urine deserves evaluation and does not automatically invalidate your genetic diagnosis.
Why Genetic Testing is the Standard
In the past, doctors used kidney biopsies (removing a small piece of kidney tissue with a needle) to diagnose kidney disease. However, for ADTKD-UMOD, a biopsy can be misleading.
- Nonspecific Results: A biopsy often just shows “interstitial fibrosis and tubular atrophy”—which basically means “generic scarring.” This doesn’t tell the doctor why the scarring is happening [12][13].
- Missing Clues: Special stains (like UMOD immunostaining) can sometimes show the protein buildup inside cells, but this isn’t always reliable [12][14].
Because of this, genetic testing is now the standard [15]. It provides a molecular diagnosis without the risks of an invasive procedure. A simple blood or saliva test can confirm the mutation and provide clarity for your entire family [14].
Reading Your Genetic Report
When you receive your genetic test results, look for these key terms:
- Pathogenic or Likely Pathogenic: These terms mean the lab is confident that the variant they found is causing the disease [1].
- UMOD: This confirms the mutation is in the uromodulin gene.
- Heterozygous: This means you have one mutated copy of the gene and one healthy copy, which is the standard pattern for ADTKD-UMOD [1].
- Variant of Uncertain Significance (VUS): This means a change was found, but the lab isn’t sure yet if it causes disease. A VUS cannot establish or exclude disease. It should never be used for predictive medical decisions, to label an asymptomatic relative, or for donor clearance [13]. Any segregation testing must be directed by a genetics specialist.
If your genetic test comes back negative but your family history is strong, a negative routine panel does not exclude all forms of ADTKD. Ask your doctor about MUC1 testing. The MUC1 mutation is a common “look-alike” for ADTKD-UMOD but requires a very specialized genetic test that standard panels often miss [15].
Common questions in this guide
What is ADTKD-UMOD, and how does it damage the kidneys?
Why can urine tests look normal in ADTKD-UMOD?
Why is genetic testing usually preferred over a kidney biopsy?
What do pathogenic, likely pathogenic, and VUS mean on a UMOD report?
Can a negative genetic panel rule out ADTKD?
Are kidney cysts required for ADTKD-UMOD, or do they mean I have ADPKD?
Should siblings or children be tested if they feel well?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my genetic report identify a 'pathogenic' or 'likely pathogenic' UMOD variant, or is it a 'variant of uncertain significance' (VUS)?
- 2.If my genetic test was negative but my family history is strong, was I tested for the MUC1 mutation, which requires a specialized test?
- 3.My urine results are 'bland'—does this confirm we should be focusing on the tubules rather than the filters (glomeruli) of my kidneys?
- 4.Are the cysts seen on my ultrasound typical for ADTKD-UMOD, or do they suggest a different condition like Polycystic Kidney Disease?
- 5.Given my specific UMOD mutation, should my siblings or children be tested even if their uric acid levels are currently normal?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.
Gonçalves F, Lisboa-Gonçalves P, Quental R, et al.
Nefrologia 2024; (44(4)):576-581 doi:10.1016/j.nefroe.2024.08.002.
PMID: 39216982 - 2
Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response.
Schaeffer C, Merella S, Pasqualetto E, et al.
PloS one 2017; (12(4)):e0175970 doi:10.1371/journal.pone.0175970.
PMID: 28437467 - 3
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.
Bazua-Valenti S, Brown MR, Zavras J, et al.
The Journal of clinical investigation 2024; (134(24)).
PMID: 39680459 - 4
Mitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease - UMOD (ADTKD-UMOD).
Kemter E, Fröhlich T, Arnold GJ, et al.
Scientific reports 2017; (7()):42970 doi:10.1038/srep42970.
PMID: 28220896 - 5
Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.
Schiano G, Lake J, Mariniello M, et al.
EMBO molecular medicine 2023; (15(12)):e18242 doi:10.15252/emmm.202318242.
PMID: 37885358 - 6
Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.
Johnson BG, Dang LT, Marsh G, et al.
The Journal of clinical investigation 2017; (127(11)):3954-3969.
PMID: 28990932 - 7
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations.
Trudu M, Schaeffer C, Riba M, et al.
Scientific reports 2017; (7(1)):7383 doi:10.1038/s41598-017-07804-6.
PMID: 28785050 - 8
Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports.
Fistrek Prlic M, Huljev Frkovic S, Beck B, et al.
Frontiers in pediatrics 2023; (11()):1283325 doi:10.3389/fped.2023.1283325.
PMID: 38027261 - 9
Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.
Ayasreh N, Bullich G, Miquel R, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(3)):411-418 doi:10.1053/j.ajkd.2018.03.019.
PMID: 29784615 - 10
Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.
Eckardt KU, Alper SL, Antignac C, et al.
Kidney international 2015; (88(4)):676-83 doi:10.1038/ki.2015.28.
PMID: 25738250 - 11
Initial Suspicion of Autosomal Dominant Polycystic Kidney Disease Resulted in a Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease Caused by a UMOD Mutation.
Usui T, Ishibashi S, Hattori A, et al.
Internal medicine (Tokyo, Japan) 2026; (65(1)):156-161 doi:10.2169/internalmedicine.5563-25.
PMID: 40533238 - 12
Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?
Onoe T, Hara S, Yamada K, et al.
BMC nephrology 2021; (22(1)):1 doi:10.1186/s12882-020-02169-x.
PMID: 33397327 - 13
Autosomal-dominant tubulointerstitial kidney disease with a novel UMOD mutation, overlapping with Sjogren's syndrome: a case report.
Nobayashi H, Iida T, Fujimaru T, et al.
CEN case reports 2025; (14(2)):113-118 doi:10.1007/s13730-024-00915-w.
PMID: 39012617 - 14
Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.
Liang D, Liang S, Zhang M, et al.
Nephron 2019; (143(4)):282-287 doi:10.1159/000502146.
PMID: 31422399 - 15
Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.
Gast C, Marinaki A, Arenas-Hernandez M, et al.
BMC nephrology 2018; (19(1)):301 doi:10.1186/s12882-018-1107-y.
PMID: 30376835
This page is for informational purposes only and does not constitute medical advice. Your nephrologist and genetics specialist should interpret your UMOD results and guide testing for you or your relatives.
Get notified when new evidence is published on familial juvenile hyperuricemic nephropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.